BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

New Book From Regulatory Affairs Professionals Society Examines Risk Management for Drugs and Medical Devices


2/5/2013 12:21:54 PM

Rockville, MD, USA—The Regulatory Affairs Professionals Society (RAPS) has published an authoritative new book covering the theory and application of risk management principles as they relate to the development and approval of drugs and medical devices.

The 145-page publication, Risk Management Principles for Devices and Pharmaceuticals: Global Perspectives on the Benefit: Risk Assessment of Medicinal Products, features 16 chapters written by 29 regulators, contractors, academics and global industry experts, representing organizations including the US Food and Drug Administration, Eli Lilly and Company, Bayer Pharma, the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) and others.

The chapter, Risk Management in the Future: Looking Into the Crystal Ball, written by Tjeerd-Pieter van Staa of MHRA, is available as free preview online, published by RAPS’ flagship publication, Regulatory Focus.

Risk Management Principles for Devices and Pharmaceuticals was co-edited by William K. Sietsema, PhD, director of regulatory affairs and global regulatory leader at Amgen Inc., who also serves as an adjunct professor of pharmaceutical sciences at the University of Cincinnati; and J. Michael Sprafka, MPH, PhD, executive director of general medicine and inflammation at the Center for Observational Research within Amgen.

“Every medical therapy has potential benefits and potential risks,” said Sietsema. “It is critical for all stakeholders to thoroughly understand the risks at each stage, from product development right on through patient treatment. Because of this, risk management has emerged in recent years as a core competency for regulatory professionals working with healthcare products.”

“The book addresses risk management issues from scientific concepts to practical application,” said Sprafka. “The authors provide great insight on preclinical planning, quality risk management, risk: benefit assessment, clinical evaluation reports, risk communication and other important topics. The diverse group of authors offers global perspectives, as well, examining risk management regulations in Australia, Canada, the EU, Japan and the US.”

Risk Management Principles for Devices and Pharmaceuticals: Global Perspectives on the Benefit: Risk Assessment of Medicinal Products is available for purchase online directly from RAPS for $44.95 for RAPS members or $54.95 for nonmembers. It is also available via Amazon.

About RAPS

The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with offices in Europe and Asia, and chapters and affiliates worldwide. RAPS.org



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES